Home » IP Update: Recent Patents, Patent Applications Awarded to Regulus; Alnylam; OSU; and More

IP Update: Recent Patents, Patent Applications Awarded to Regulus; Alnylam; OSU; and More

Feb 09, 2012
Premium

Title: Oligomeric Compounds and Compositions for Use in Modulation of Small Non-Coding RNAs

Patent Number: 8,110,558

Filed: Dec. 31, 2008

Lead Inventor: Frank Bennett, Regulus Therapeutics

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Double-Blinded Not Preferred Review

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

This Week in PNAS

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

Grand Trees, Large Genomes

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

DNA Defense Not Convincing

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

What's Popular?

In Gene Silencing/Gene Editing

  1. Researchers Develop Genome Editing Technique Without Double-Stranded DNA Breaks

  2. Researchers Use CRISPR to Explore Genes Relevant to Human Embryonic Development

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.